We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
(-83%)
Cap. Flow
-$6.76B
Cap. Flow
% of AUM
-444.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
First Horizon
FHN
|
+$107M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$54.9M |
| 4 |
VMW
VMware, Inc
VMW
|
+$34.9M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
Rogers Corp
ROG
|
+$432M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.54% |
| 2 | Healthcare | 36.97% |
| 3 | Financials | 14.43% |
| 4 | Communication Services | 3.06% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Keros Therapeutics
KROS
$211M
| – | – |
-33,321
| Closed | -$1.25M |
|
|
LADR
177
Ladder Capital
LADR
$1.21B
| – | – |
-137,322
| Closed | -$1.23M |
|
178
PUT
Lamar Advertising Co
LAMR
$16.2B
| – | – |
-220,000
| Closed | -$280K |
|
|
LDTC
179
DELISTED
LeddarTech
LDTC
| – | – |
-949,752
| Closed | -$4.74M |
|
180
Lennar Class B
LEN.B
$20.1B
| – | – |
-19,196
| Closed | -$1.09M |
|
181
Linde
LIN
$226B
| – | – |
-24,821
| Closed | -$6.69M |
|
182
Eli Lilly
LLY
$1.06T
| – | – |
-4,600
| Closed | -$1.49M |
|
183
LanzaTech
LNZA
$68M
| – | – |
-7,159
| Closed | -$7.01M |
|
184
PUT
Lumen
LUMN
$6.09B
| – | – |
-128,000
| Closed | -$621K |
|
185
Southwest Airlines
LUV
$23B
| – | – |
-85,791
| Closed | -$2.65M |
|
|
LVTX
186
DELISTED
LAVA Therapeutics
LVTX
| – | – |
-75,000
| Closed | -$343K |
|
187
PUT
Macy's
M
$6.61B
| – | – |
-164,500
| Closed | -$606K |
|
188
Mid-America Apartment Communities
MAA
$15.5B
| – | – |
-37,905
| Closed | -$5.88M |
|
189
PUT
Marriott International
MAR
$93.8B
| – | – |
-11,000
| Closed | -$135K |
|
190
Mattel
MAT
$4.21B
| – | – |
-898,836
| Closed | -$17M |
|
191
Spectral AI
MDAI
$52.8M
| – | – |
-304,551
| Closed | -$3M |
|
192
MDU Resources
MDU
$4.34B
| – | – |
-322,548
| Closed | -$3.35M |
|
193
Methanex
MEOH
$4.21B
| – | – |
-77,746
| Closed | -$2.48M |
|
194
M/I Homes
MHO
$3.71B
| – | – |
-17,233
| Closed | -$624K |
|
195
Martin Marietta Materials
MLM
$32.3B
| – | – |
-27,002
| Closed | -$8.7M |
|
196
Merck
MRK
$317B
| – | – |
-22,800
| Closed | -$1.96M |
|
|
MRSN
197
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-15,060
| Closed | -$2.54M |
|
198
Marti Technologies
MRT
$154M
| – | – |
-238,623
| Closed | -$2.38M |
|
|
MRUS
199
DELISTED
Merus
MRUS
| – | – |
-77,116
| Closed | -$1.54M |
|
200
MultiSensor AI
MSAI
$10.3M
| – | – |
-5,966
| Closed | -$2.39M |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
- UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
- UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.